THE LIVINGSTON GROUP, LLC OBO INNOVATIVE VACCINE TECHNOLOGIES

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2024–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1
2024	—	5	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
OCULUS STRATEGIES, LLC	—	12

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	11
SENATE	11
Army, Dept of (Other)	2

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Defense	Defense	12

Bills Explicitly Cited (20)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 9495119th Congress

Department of Defense Appropriations Act, 2027

2026 · third_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR 9495, S ____, FY2027 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

Client expense: — · Firm income: —

Matched citations: HR 9495

H.R. 9495119th Congress

Department of Defense Appropriations Act, 2027

2026 · second_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR 9495, S ____, FY2027 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

Client expense: — · Firm income: —

Matched citations: HR 9495

H.R. 3838119th Congress

Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026

2025 · fourth_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3838, S 2296, FY2026 National Defense Authorization Act HR 4016, S 2572, FY2026 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

Client expense: — · Firm income: —

Matched citations: HR 3838

H.R. 4016119th Congress

Department of Defense Appropriations Act, 2026

2025 · fourth_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3838, S 2296, FY2026 National Defense Authorization Act HR 4016, S 2572, FY2026 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

Client expense: — · Firm income: —

Matched citations: HR 4016

Show 16 more cited filings

S. 2296119th Congress

National Defense Authorization Act for Fiscal Year 2026

2025 · fourth_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3838, S 2296, FY2026 National Defense Authorization Act HR 4016, S 2572, FY2026 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

Client expense: — · Firm income: —

Matched citations: S 2296

S. 2572119th Congress

Department of Defense Appropriations Act, 2026

2025 · fourth_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3838, S 2296, FY2026 National Defense Authorization Act HR 4016, S 2572, FY2026 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

Client expense: — · Firm income: —

Matched citations: S 2572

H.R. 3838119th Congress

Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026

2025 · third_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3838, S 2296, FY2026 National Defense Authorization Act HR 4016, S 2572, FY2026 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

Client expense: — · Firm income: —

Matched citations: HR 3838

H.R. 4016119th Congress

Department of Defense Appropriations Act, 2026

2025 · third_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3838, S 2296, FY2026 National Defense Authorization Act HR 4016, S 2572, FY2026 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

Client expense: — · Firm income: —

Matched citations: HR 4016

S. 2296119th Congress

National Defense Authorization Act for Fiscal Year 2026

2025 · third_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3838, S 2296, FY2026 National Defense Authorization Act HR 4016, S 2572, FY2026 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

Client expense: — · Firm income: —

Matched citations: S 2296

S. 2572119th Congress

Department of Defense Appropriations Act, 2026

2025 · third_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3838, S 2296, FY2026 National Defense Authorization Act HR 4016, S 2572, FY2026 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

Client expense: — · Firm income: —

Matched citations: S 2572

H.R. 3838119th Congress

Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026

2025 · second_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3838, S 2296, FY2026 National Defense Authorization Act HR 4016, S ___, FY2026 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

Client expense: — · Firm income: —

Matched citations: HR 3838

H.R. 4016119th Congress

Department of Defense Appropriations Act, 2026

2025 · second_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3838, S 2296, FY2026 National Defense Authorization Act HR 4016, S ___, FY2026 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

Client expense: — · Firm income: —

Matched citations: HR 4016

S. 2296119th Congress

National Defense Authorization Act for Fiscal Year 2026

2025 · second_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3838, S 2296, FY2026 National Defense Authorization Act HR 4016, S ___, FY2026 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

Client expense: — · Firm income: —

Matched citations: S 2296

H.R. 1968119th Congress

Full-Year Continuing Appropriations and Extensions Act, 2025

2025 · first_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 8774 and S. 4921 FY 25 Defense Appropriations Act (RDT&E Sections), H.R. 1968 FY2025 Full-Year Continuing Appropriations and Extensions Act (Defense Division, RDT&E Section), FY26 House and Senate Defense Appropriations Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R. 1968

H.R. 8774119th Congress

Bulletproof Law Enforcement Vehicles Act

2025 · first_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 8774 and S. 4921 FY 25 Defense Appropriations Act (RDT&E Sections), H.R. 1968 FY2025 Full-Year Continuing Appropriations and Extensions Act (Defense Division, RDT&E Section), FY26 House and Senate Defense Appropriations Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R. 8774

S. 4921119th Congress

Blair Holt Firearm Owner Licensing and Record of Sale Act of 2026

2025 · first_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 8774 and S. 4921 FY 25 Defense Appropriations Act (RDT&E Sections), H.R. 1968 FY2025 Full-Year Continuing Appropriations and Extensions Act (Defense Division, RDT&E Section), FY26 House and Senate Defense Appropriations Act.

Client expense: — · Firm income: $10,000

Matched citations: S. 4921

S. 4921118th Congress

Department of Defense Appropriations Act, 2025

2024 · fourth_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H>8774 and S 4921, FY2025 Defense Appropriations Act, RDT&E Title for vaccine product dev.

Client expense: — · Firm income: $10,000

Matched citations: S 4921

S. 4921118th Congress

Department of Defense Appropriations Act, 2025

2024 · third_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H>8774 and S 4921, FY2025 Defense Appropriations Act, RDT&E Title for vaccine product dev.

Client expense: — · Firm income: $10,000

Matched citations: S 4921

H.R. 4365118th Congress

Department of Defense Appropriations Act, 2024

2024 · first_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 4365, FY25 Defense Appropriations Act, RDT&E Title; S.2587 Senate FY25 Defense Appropriations Act, RDT&E Title; synthetic vaccine

Client expense: — · Firm income: —

Matched citations: H.R. 4365

S. 2587118th Congress

Department of Defense Appropriations Act, 2024

2024 · first_quarter · Firm: OCULUS STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 4365, FY25 Defense Appropriations Act, RDT&E Title; S.2587 Senate FY25 Defense Appropriations Act, RDT&E Title; synthetic vaccine

Client expense: — · Firm income: —

Matched citations: S.2587

Source: Senate LDA

THE LIVINGSTON GROUP, LLC OBO INNOVATIVE VACCINE TECHNOLOGIES — Lobbying Disclosure | Poliscope